Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (5.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 41.00
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Celerum appoints David Gladding as CEO

9 Jan 2023 07:00

RNS Number : 9966L
Frontier IP Group plc
09 January 2023
 

Reach - a non-regulatory announcement

AIM: FIPP

9 January 2023

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

 

Portfolio news - Celerum appoints David Gladding as Chief Executive Officer

 

Frontier IP, a specialist in commercialising intellectual property, today announces that portfolio company Celerum Limited ("Celerum" or the "Company") has appointed David Gladding as Chief Executive Officer.

 

His experience in the software industry will help drive both the commercial and technical development of the Company's novel artificial intelligence-based metaheuristics, including nature inspired computing ("NIC"), to make logistics more efficient.

 

Celerum is at an important stage of development. The Company launched its first commercial product, Truck Logistics System (TLS), earlier this year to cut road haulage costs, carbon emissions and delivery times for small to medium-sized truck fleets, which is now winning customers. The first was Colin Lawson Transport, a haulage firm based in Aberdeen, operating 75 trucks and about 150 trailers. Frontier IP holds a 33.8 per cent equity stake in the Company.

David has more than 30 years' experience at senior levels in software and IT services companies, including those specialising in fleet management. He was Senior Vice President Global Sales for Chevin Fleet Solutions and has also worked for Civica and Fleet Clear over the past 12 years gaining a wide and in-depth understanding of the industry.

 

Other potential applications for the technology are in the maritime, energy, and telecommunication sectors where positive use cases have already been identified.

 

The technology is based on more than 25 years' research into metaheuristics by Celerum founder and chair Professor John McCall, Head of the School of Computing, Science and Digital Media at Robert Gordon University, Aberdeen. He is a director of the Company and continues to support development of the software.

 

Metaheuristic algorithms lie at the heart of Celerum's technology. They are designed to find the best solution out of a range of possible solutions to particularly complex problems. A subset of these is NIC algorithms, which use lessons from the natural world where evolution has overcome inefficiency. For example, bees and ants are extremely good at finding the best routes to food sources or returning to their nests.

 

Researchers have found metaheuristic algorithms achieve a high degree of accuracy when used to predict and propose "what if" scenarios, providing a basis to explore. This formed the basis to explore industry applications.

 

Unlike other forms of AI, such as machine learning, algorithms based on metaheuristics do not need to be trained on past data or special training datasets, helping to make Celerum's software easy to deploy. It needs no special hardware and resides in the cloud to give customers access to an evolving platform. Celerum's AI works as soon as it is activated to enable customers to take advantage of opportunities sooner than most other systems.

Celerum Chief Executive Officer David Gladding said: "I am excited to be joining Celerum at this time. We have an opportunity to help businesses understand what their data is telling them, giving them easy access to very smart technology that will help simplify complex business challenges. The real power behind our AI is how it helps educate users when interrogating data to increase their success of making informed business decisions. Whilst our platform is industry agnostic, we have won customers from the fleet management industry, which is worth $27 billion a year globally. Our platform is unique in this market, and I am expecting to see a great deal of interest. We know that this market is intensely competitive, where every marginal gain is important, and we believe our software can give customers an important edge in efficiency and productivity gains, cutting costs and making their operations greener."

Professor John McCall, Head of the School of Computing, Science and Digital Media at Robert Gordon University, Aberdeen, and Celerum director said: "David has a very keen interest in how we use data to improve business efficiencies and reducing the carbon footprint, along with his vast experience in software and the fleet industry, we are excited that David is leading Celerum to future success".

Neil Crabb, Frontier IP Chief Executive Officer, said: "I am delighted with David's appointment as Celerum's Chief Executive. His experience means he is the right person to drive the Company forward following the successful launch of its first commercial product."

 

 

ENQUIRIES

 

Frontier IP Group Plc

T: 020 7332 2338

Neil Crabb, Chief Executive Officer

Andrew Johnson, Communications and investor relations

andrew.johnson@frontierip.co.uk

Company website: www.frontierip.co.uk

 

 

neil@frontierip.co.uk

M: 07464 546 025

Allenby Capital Limited (Nominated Adviser)

Nick Athanas / George Payne

 

T: 0203 328 5656

 

 

 

 

ABOUT METAHEURISTICS

Metaheuristics are a development of heuristics: a heuristic is a cognitive short cut used by humans and computers to arrive at a decision or solution in the face of confusing and sometimes conflicting data.

Metaheuristic algorithms are designed to derive the best possible solutions to complex problems where there are no perfect answers. These problems could involve incomplete or imperfect data, unpredictability, tight timeframes, unpredictability, and limited computing power.

There are many different strategies used to develop metaheuristic algorithms. They include local search, where an existing, single solution is refined to develop an optimal answer; global search, where several solutions are collectively refined to solve a problem in the best way; and nature inspired computing, where lessons from the natural world are applied.

An algorithm based on the theory of evolution, for example, will test many potential answers until the "fittest" emerges.

Often different metaheuristic approaches are combined - a development known as hybrid metaheuristics. They can be applied to many different problems. Unlike other forms of artificial intelligence, such as machine learning, metaheuristics do not have to be trained on large datasets.

Celerum has applied these methodologies and developed bespoke algorithms specifically for logistic companies to help them tackle the complexity of managing many trucks and drivers. Many firms currently rely on multiple legacy systems.

Because of the way metaheuristics work, they are very efficient in terms of the amount of data they process. Metaheuristic algorithms do not need to be trained on large datasets. Therefore, they provide a very cost-effective way to reach an intelligent solution that would otherwise be out of reach for many small to medium size logistic businesses. The algorithms are able to work on everyday computers, mobile phones and other devices.

 

ABOUT FRONTIER IP

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

About Reach announcements

 

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

 

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAQQLFBXFLXBBE
Date   Source Headline
6th Dec 20196:25 pmRNSHolding(s) in Company
5th Dec 201912:00 pmRNSHolding(s) in Company
4th Dec 201912:00 pmRNSResult of AGM & Total Voting Rights
26th Nov 201912:58 pmRNSHolding(s) in Company
13th Nov 20195:00 pmRNSPosting of Annual Report and Accounts
7th Nov 201912:20 pmRNSHolding(s) in Company
6th Nov 20192:00 pmRNSResult of Placing
6th Nov 20197:01 amRNSProposed fundraising of £3.5m by way of Placing
6th Nov 20197:00 amRNSFinal Results
22nd Oct 20197:00 amRNSAppointment of senior advisers
15th Oct 20197:00 amRNSNew portfolio company: Elute Intelligence Holdings
10th Sep 20197:00 amRNSAppointment of Broker
25th Jul 20197:00 amRNSExscientia collaboration with Rallybio
15th Jul 201912:08 pmRNSHolding(s) in Company
14th Jun 20197:00 amRNSExscientia partnership with GT Apeiron
31st May 20195:00 pmRNSTotal Voting Rights
31st May 20193:15 pmRNSDirectorate Change
28th May 20197:00 amRNSFieldwork Robotics completes initial field trials
15th May 20197:00 amRNSDirector exercise of options, shareholding and TVR
10th May 201911:48 amRNSHolding(s) in Company
30th Apr 20197:00 amRNSEuropean plan to boost marine & coastal economies
8th Apr 20197:00 amRNSParkside Architectural Tiles launch Alusid range
8th Apr 20197:00 amRNSBosch UK to work with Pulsiv Solar
8th Apr 20197:00 amRNSInvestor event at the Royal Academy of Engineering
4th Apr 20197:00 amRNSExscientia reaches first major milestone with GSK
3rd Apr 20195:51 pmRNSHolding(s) in Company
3rd Apr 20193:45 pmRNSHolding(s) in Company
1st Apr 20197:00 amRNSFieldwork Robotics wins Innovate UK ISCF grant
27th Mar 20191:30 pmRNSHolding(s) in Company
27th Mar 20191:30 pmRNSHolding(s) in Company
27th Mar 20197:00 amRNSBoard Appointment
27th Mar 20197:00 amRNSUnaudited Half Year Results
21st Mar 20199:18 amRNSTrading Update
21st Mar 20199:14 amRNSExscientia & Celgene drug discovery collaboration
6th Mar 20195:15 pmRNSHolding(s) in Company
20th Feb 20197:00 amRNSTVG - key partner in $9.67m DARPA project award
12th Feb 20197:00 amRNSThird Portuguese spin out: Insignals Neurotech
4th Feb 20197:00 amRNSAmprologix wins DHSC backing for new antibiotic
31st Jan 20199:00 amRNSNandi Proteins led consortium wins UK grant
25th Jan 20197:00 amRNSThe Vaccine Group wins Department of Health grant
7th Jan 20191:29 pmRNSExscientia Series B funding & Roche collaboration
27th Dec 20187:00 amRNSMolendotech - Palintest start commercial roll out
19th Dec 201811:45 amRNSResult of AGM
30th Nov 20185:30 pmRNSTotal Voting Rights
23rd Nov 201812:10 pmRNSPosting of Annual Report and Notice of AGM
22nd Nov 20181:12 pmRNSHolding(s) in Company
22nd Nov 201810:36 amRNSHolding(s) in Company
21st Nov 20183:30 pmRNSHolding(s) in Company
21st Nov 201811:00 amRNSTotal Voting Rights and Director/PDMR Shareholding
15th Nov 20184:08 pmRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.